● Checkout.com 发布首期《海外数字经济信任度报告》，基于消费者对安全性、透明度及用户体验感知 的国家排名 ● 中东北非地区位居数字经济信任度榜首，而欧美地区因对辅助消费 AI 工具的高度不信任而表现滞后 ● 该报告首次揭示消费者数字信任度与国家 GDP 增长的相关性 伦敦，2025年5月14日——全球领先数字支付服务商 Checkout.com 今日发布首份《海外数字经济信任度 报告》，该报告基于对 16 个国家消费者数字支付安全、透明度及用户体验的信任度评估，首次发现 2014-2024 年间消费者数字信任度与国家 GDP 增长率呈显著正相关，印证数字经济信任度已成为现代 经济增长的关键驱动力。 埃及地区以接近 7 分(满分 10 分)高居该指数榜首，阿联酋和沙特阿拉伯紧随其后。值得注意的是，尽 管日本的数字化和电商普及率较高，却仅有 2.6 分的信任评分，意外垫底。 《海外数字经济信任度报告》在全面反映个人与数字系统的互动、信任及采用情况，助力企业、政策制 定者和技术服务商洞悉关键信任驱动因素与障碍，最终通过提升数字经济信任度推动更广泛的经济增 长。在所有市场调研的 18 个维度中，与总体信 ...

Core Insights - Codexis, Inc. has appointed Cynthia Collins to its Board of Directors, bringing extensive experience in the pharmaceutical and biotech industry [1][2] - The company aims to expand its commercial footprint with its ECO Synthesis toolbox, which is positioned to unlock the potential of RNA-based therapeutics [2] Company Overview - Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, utilizing its proprietary CodeEvolver® technology platform [3] - The company is developing the ECO Synthesis™ manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route [3] - Codexis' unique enzymes are designed to improve yields, reduce energy usage and waste generation, and enhance efficiency in manufacturing [3] Leadership Background - Cynthia Collins has over four decades of experience in the pharmaceutical and biotech sectors, currently serving as Executive Chair and interim CEO of Nutcracker Therapeutics [2] - Her previous roles include CEO of Editas Medicine, where she oversaw the first clinical trial of an in vivo CRISPR gene editing therapy, and various leadership positions at GE Healthcare and Baxter Healthcare [2]

Market Overview - The global ultrasound image analysis software market is estimated to be USD 0.913 billion in 2024 and is expected to reach USD 2.20 billion by 2035, with a CAGR of 8.34% during the forecast period 2025-2035 [1][17]. Technological Advancements - The market growth is driven by advancements in ultrasound technology, particularly in image processing and AI-powered analysis, including developments such as 3D and 4D imaging, elastography, and Doppler imaging [4]. - These technological improvements enhance image quality, automate measurements, and enable real-time visualization, leading to increased demand for sophisticated ultrasound image analysis software [4][5]. Regional Insights - North America is anticipated to have the highest revenue share during the forecast period due to its well-established healthcare infrastructure and high adoption of advanced imaging technologies [6]. - The Asia Pacific region is predicted to grow at the fastest CAGR, driven by an expanding healthcare sector, increasing government investments, and rising prevalence of chronic diseases in emerging markets like China and India [7]. Market Segmentation by Type - The integrated software segment accounted for the highest revenue in 2024, driven by the adoption of comprehensive diagnostic solutions that enhance workflow efficiency [8]. - The standalone software segment is expected to grow at the fastest CAGR, catering to specific clinical needs in smaller clinics and diagnostic centers [9]. Market Segmentation by Product - The Doppler imaging segment accounted for the highest revenue in 2024, widely used in vascular imaging, obstetrics, and cardiology [10]. - The 3D & 4D ultrasound systems segment is predicted to grow at the fastest CAGR due to its advanced imaging capabilities [11]. Market Segmentation by Application - The cardiology segment accounted for the highest revenue in 2024, driven by the increasing prevalence of cardiovascular diseases [12]. - The oncology segment is expected to grow at the fastest CAGR, leveraging advanced image analysis tools for cancer detection and monitoring [13]. Market Segmentation by End-User - The hospitals segment accounted for the highest revenue in 2024, attributed to high patient volume and advanced infrastructure [14]. - The diagnostic centers segment is predicted to grow at the fastest CAGR, driven by the demand for quick and accurate diagnostic solutions [16].